Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 26, 2012
Wed, July 25, 2012 Market Maker Surveillance Report. DELL, ARNA, AMD, HGSI, GWBU, SPOW, Highest Net Sell Volume and Negative Price Friction For W
July 25, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4023 companies with "abnormal" market making, 2567 companies with positive Friction Factors and 2499 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Wednesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Dell Inc (NASDAQ:DELL), Arena Pharmaceuticals Inc (NASDAQ:ARNA), Advanced Micro Devices Inc (NYSE:AMD), Human Genome Sciences Inc (NASDAQ:HGSI), Great Wall Builders Ltd (OTCBB:GWBU), Sky Power Solutions Corp (OTCBB:SPOW). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction DELL $-0.080 -0.68% 10,105,834 43.61% 13,041,135 56.27% -2,935,301 -366,913 ARNA $-0.230 -2.32% 3,339,920 33.57% 6,601,377 66.34% -3,261,457 -141,802 AMD $-0.040 -0.99% 4,328,559 21.84% 8,611,746 43.46% -4,283,187 -1,070,797 HGSI $-0.010 -0.04% 1,971,334 24.69% 6,012,113 75.31% -4,040,779 -4,040,779 GWBU $-0.018 -20.00% 3,433,896 34.86% 6,416,488 65.14% -2,982,592 -1,656,996 SPOW $-0.012 -40.00% 5,041,536 33.25% 10,122,892 66.75% -5,081,356 -4,234,463Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows DELL down $-0.08000 with a Friction Factor of -366,913 and a Net Volume of -2,935,301. That means that it takes 366,913 more shares of selling than buying to drop DELL by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).
Dell Inc (NASDAQ:DELL) - Dell Inc. provides integrated technology solutions in the information technology (IT) industry worldwide. The company designs, develops, manufactures, markets, sells, and supports mobility products, including laptops, netbooks, tablets, and smartphones; desktops PCs; and servers and networking products. It also offers storage solutions comprising storage area networks, network-attached storage, direct-attached storage, disk and tape backup systems, and removable disk backup. In addition, the company provides third-party software products consisting of operating systems, business and office applications, anti-virus and related security software, and entertainment software; and peripherals, such as printers, televisions, notebook accessories, mice, keyboards, networking and wireless products, and digital cameras. In addition, it offers IT and business services, including transactional services, such as support, managed deployment, enterprise installation, and configuration services; outsourcing services comprising data center and systems management, network management, life cycle application development and management, and business process outsourcing services; and project-based services consisting of IT infrastructure, applications, business process, and business consulting services, as well as offers asset recovery, recycling, and applications maintenance services. Further, the company provides financial services, including originating, collecting, and servicing customer receivables related to the purchase of its products. Dell Inc. sells its products and services through its sales representatives, telephone-based sales, and online at dell.com, as well as through indirect sales channels. The company was founded in 1984 and is headquartered in Round Rock, Texas.
Arena Pharmaceuticals Inc (NASDAQ:ARNA) - Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin that has completed Phase III clinical trials for the treatment of weight management; APD791, an anti-thrombotic drug candidate, which completed Phase Ia and Phase Ib clinical trials; APD597 that is in Phase I clinical trials for the treatment of type II diabetes; APD916, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. The companys drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including Constitutively Activated Receptor Technology and Melanophore Technology. It has collaboration agreements with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type II diabetes and other disorders; and Merck & Co., Inc. to develop therapeutics for atherosclerosis and other disorders. Arena Pharmaceuticals also has a strategic cooperation agreement with Siegfried Ltd to manufacture lorcaserin. The company was founded in 1997 and is based in San Diego, California.
Advanced Micro Devices Inc (NYSE:AMD) - Advanced Micro Devices, Inc. operates as a semiconductor company in the United States, Japan, China, and Europe. Its microprocessors for server platforms include multi-core AMD Opteron processors; notebook PC platforms consist of the AMD Dual-Core Accelerated Processor E-350, AMD Dual-Core Accelerated Processor C-50, AMD Phenom II Dual-Core Mobile Processor, AMD Phenom II Quad-Core Mobile Processor, AMD Turion X2 Mobile Processor, AMD Turion II Mobile Processor, AMD Turion II Ultra Mobile Processor, AMD Turion Neo X2 Mobile Processor, AMD Athlon II processor, AMD Athlon Neo processor, AMD Athlon Neo X2 Dual-Core processor, and the Mobile AMD Sempron processor products; and desktop PC platforms comprise AMD Phenom II, AMD Phenom, AMD Athlon II, AMD Athlon X2, AMD Athlon, and AMD Sempron processors. It also provides embedded processor products for vendors in industrial controls, digital signage, point of sale/self-service kiosks, medical imaging, set-top box, and casino gaming machines, as well as enterprise class telecommunications, networking, security, storage systems and thin-clients, or computers. In addition, the company offers chipset products, including integrated graphics processor chipsets and discrete chipsets for desktop and notebook PCs, professional workstations, and servers. Further, it provides graphic products consisting of 3D graphics, and video and multimedia products for use in desktop and notebook computers, such as home media PCs, professional workstations, and servers, as well as technology for game consoles. The company's graphics products comprise discrete desktop graphics, discrete notebook graphics, professional graphics, FireStream processors, and game consoles. It serves original equipment manufacturers, original design manufacturers, system builders, and independent distributors through direct sales force, independent distributors, and sales representatives. The company was founded in 1969 and is based in Sunnyvale, California.
Human Genome Sciences Inc (NASDAQ:HGSI) - Human Genome Sciences, Inc. operates as a biopharmaceutical company. Its principal products in development include BENLYSTA for systemic lupus erythematosus; and raxibacumab for inhalation anthrax. The companys mid- and early-stage pipeline products comprise Mapatumumab for the treatment of non-small cell lung cancer, multiple myeloma, and hepatocellular cancer; IAP Inhibitors that are compounds, which block the activity of IAP (inhibitor of apoptosis) proteins, allowing apoptosis to proceed and causing the cancer cells to die; and CCR5 mAb, a human monoclonal antibody to the CCR5 receptor for the treatment of ulcerative colitis. Human Genome Sciences, Inc. also holds financial rights to certain products in the GlaxoSmithKline clinical development pipeline, including darapladib, a Phase III clinical trial product for the treatment of coronary heart disease and ischemic stroke; and Albiglutide for the treatment for type 2 diabetes, which is in Phase III clinical trial stage. The company has a license agreement with GlaxoSmithKline for the co-development and commercialization of BENLYSTA; and a collaboration and license agreement with Aegera Therapeutics, Inc. to develop and commercialize certain oncology molecules and related backup compounds. Human Genome Sciences, Inc. was founded in 1992 and is headquartered in Rockville, Maryland.
Great Wall Builders Ltd (OTCBB:GWBU) - Great Wall Builders Ltd., a development stage company, focuses to provide homes in the United States and China. It plans to design and sell homes with solar integrated systems, such as solar integrated roof tiles, solar hot water heaters, and solar electric photovoltaic systems. The company intends to market its products through commissioned employees and independent real estate brokers. Great Wall Builders Ltd. was founded in 2007 and is based in Houston, Texas.
Sky Power Solutions Corp (OTCBB:SPOW) -
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net
- WOPRAI
- support@woprai.com